| Mandalyn P Smith, CRNP | |
|
217 Dothan Rd, Abbeville, AL 36310-2836 | |
| (334) 585-6421 | |
| Not Available |
| Full Name | Mandalyn P Smith |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 217 Dothan Rd, Abbeville, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912348715 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1-121618 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeast Alabama Medical Center | Dothan, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hearts South Pc | 7810933751 | 7 |
News Archive
Oceana Therapeutics LLC, a privately owned global company focused on commercializing best-in-class specialty therapeutics, today announced it has entered into a definitive agreement for the sale of its operating subsidiary, Oceana Therapeutics, Inc. to Salix Pharmaceuticals, Ltd. of Raleigh, NC.
University of Warwick researchers have developed a superior method to describe the very earliest effects that Alzheimer's Disease proteins have on the properties of brain cells.
Virtually all patients who develop myeloma have an asymptomatic disease called monoclonal gammopathy of undetermined significance (MGUS) in the years before the onset of myeloma. The five-year relative survival rate for myeloma is 69% for patients diagnosed with stage I or localized disease, compared with 45% for patients with advanced cancer.
Scientists fear a new Ebola strain might emerge in the Democratic Republic of Congo if two versions of the disease mix together to form a new, potentially deadlier version.
› Verified 3 days ago
| Entity Name | Hearts South Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790987238 PECOS PAC ID: 7810933751 Enrollment ID: O20050630001066 |
News Archive
Oceana Therapeutics LLC, a privately owned global company focused on commercializing best-in-class specialty therapeutics, today announced it has entered into a definitive agreement for the sale of its operating subsidiary, Oceana Therapeutics, Inc. to Salix Pharmaceuticals, Ltd. of Raleigh, NC.
University of Warwick researchers have developed a superior method to describe the very earliest effects that Alzheimer's Disease proteins have on the properties of brain cells.
Virtually all patients who develop myeloma have an asymptomatic disease called monoclonal gammopathy of undetermined significance (MGUS) in the years before the onset of myeloma. The five-year relative survival rate for myeloma is 69% for patients diagnosed with stage I or localized disease, compared with 45% for patients with advanced cancer.
Scientists fear a new Ebola strain might emerge in the Democratic Republic of Congo if two versions of the disease mix together to form a new, potentially deadlier version.
› Verified 3 days ago
| Entity Name | Northern Alabama Physicians, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669618310 PECOS PAC ID: 0143379388 Enrollment ID: O20090519000375 |
News Archive
Oceana Therapeutics LLC, a privately owned global company focused on commercializing best-in-class specialty therapeutics, today announced it has entered into a definitive agreement for the sale of its operating subsidiary, Oceana Therapeutics, Inc. to Salix Pharmaceuticals, Ltd. of Raleigh, NC.
University of Warwick researchers have developed a superior method to describe the very earliest effects that Alzheimer's Disease proteins have on the properties of brain cells.
Virtually all patients who develop myeloma have an asymptomatic disease called monoclonal gammopathy of undetermined significance (MGUS) in the years before the onset of myeloma. The five-year relative survival rate for myeloma is 69% for patients diagnosed with stage I or localized disease, compared with 45% for patients with advanced cancer.
Scientists fear a new Ebola strain might emerge in the Democratic Republic of Congo if two versions of the disease mix together to form a new, potentially deadlier version.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mandalyn P Smith, CRNP 217 Dothan Rd, Abbeville, AL 36310-2836 Ph: (334) 585-6421 | Mandalyn P Smith, CRNP 217 Dothan Rd, Abbeville, AL 36310-2836 Ph: (334) 585-6421 |
News Archive
Oceana Therapeutics LLC, a privately owned global company focused on commercializing best-in-class specialty therapeutics, today announced it has entered into a definitive agreement for the sale of its operating subsidiary, Oceana Therapeutics, Inc. to Salix Pharmaceuticals, Ltd. of Raleigh, NC.
University of Warwick researchers have developed a superior method to describe the very earliest effects that Alzheimer's Disease proteins have on the properties of brain cells.
Virtually all patients who develop myeloma have an asymptomatic disease called monoclonal gammopathy of undetermined significance (MGUS) in the years before the onset of myeloma. The five-year relative survival rate for myeloma is 69% for patients diagnosed with stage I or localized disease, compared with 45% for patients with advanced cancer.
Scientists fear a new Ebola strain might emerge in the Democratic Republic of Congo if two versions of the disease mix together to form a new, potentially deadlier version.
› Verified 3 days ago
Robert Craig Espy, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 217 Dothan Rd, Abbeville, AL 36310 Phone: 334-585-6421 | |
Meredith Mcneal, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 217 Dothan Rd, Abbeville, AL 36310 Phone: 334-585-6421 |